CLINICAL TRIAL
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Organized left atrial tachyarrhythmia during stepwise linear ablation for atrial fibrillation.

INTRODUCTION: This study attempted to delineate the mechanism of organized left atrial tachyarrhythmia (AT) during stepwise linear ablation for atrial fibrillation (AF) using noncontact mapping.

METHODS AND RESULTS: Eighty patients in whom organized ATs developed or induced during stepwise linear ablation for AF were enrolled. Left atrial (LA) activation during ATs was mapped using noncontact mapping. Radiofrequency (RF) energy was delivered to the earliest activation site or narrowest part of the reentrant circuit of ATs. A total of 146 ATs were mapped. Four ATs were characterized as a focal mechanism (cycle length (CL): 225 +/- 49 ms). A macroreentrant mechanism was confirmed in the remaining 142 ATs. LA activation time accounted for 100% of CL (205 +/- 37 ms). All 142 ATs used the conduction gaps in the basic figure-7 lesion line. There were three types of circuits classified based on the gap location. Type I (n = 68) used gaps at the ridge between left atrial appendage (LAA) and left superior pulmonary vein (LSPV). Type II (n = 50) used gaps on the LA roof. Type III (n = 24) passed through gaps in the mitral isthmus. Ablation at these gaps eliminated 130 ATs. During the follow-up period of 16.2 +/- 6.7 months, 82.5% of the 80 patients were in sinus rhythm.

CONCLUSION: The majority of left ATs developed during stepwise linear ablation for AF are macroreentrant through conduction gaps in the figure-7 lesion line, especially at the LAA-LSPV ridge. Noncontact activation mapping can identify these gaps accurately and quickly to target effective catheter ablation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app